CN1341603A - Synthesis method of pregnen ketoalcohol compound - Google Patents

Synthesis method of pregnen ketoalcohol compound Download PDF

Info

Publication number
CN1341603A
CN1341603A CN 01113196 CN01113196A CN1341603A CN 1341603 A CN1341603 A CN 1341603A CN 01113196 CN01113196 CN 01113196 CN 01113196 A CN01113196 A CN 01113196A CN 1341603 A CN1341603 A CN 1341603A
Authority
CN
China
Prior art keywords
acid
sapogenin
acetate
nsc
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 01113196
Other languages
Chinese (zh)
Other versions
CN1146574C (en
Inventor
田伟生
刘闪闪
沈军伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Organic Chemistry of CAS
Original Assignee
Shanghai Institute of Organic Chemistry of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry of CAS filed Critical Shanghai Institute of Organic Chemistry of CAS
Priority to CNB011131969A priority Critical patent/CN1146574C/en
Publication of CN1341603A publication Critical patent/CN1341603A/en
Application granted granted Critical
Publication of CN1146574C publication Critical patent/CN1146574C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

In the organic solvent it uses hydrogen perioxide to oxidate psudosapogenin to obtain pregnene keto-alcohol and 4-methyl-delta-butyrolactone. The obtained pregnene keto-alcohol is a key precursor for synthesizing steroid medicine. The 4-methyl-delta-butyrolactone can be used for synthesizing chiral methyl contained compounds of chiral liquid crystal and insect pheromone, etc. Said invented method is moderate is condition, low in cost, has no pollution and its reaction yield is equal to or greater than that of chrome-anhydride oxidation method.

Description

A kind of new NSC 37741 compound synthesizes method
The present invention relates to the synthetic method of a kind of new NSC 37741 compound, promptly in organic solvent, use the false steroid sapogenines (Psudosapogenin) of catalytic oxidation of hydrogen peroxide, obtain NSC 37741 and 3-methyl-δ-butyrolactone.
In state-owned abundant steroid sapogenines resource, as diosgenin, sisalagenin, zhimusaponin unit, luxuriant numb sapogenin etc., they are basic raw materials of making various steroid drugss.Utilize steroid sapogenines synthesizing steroid medicine, at first need steroid sapogenin degradation is become the NSC 37741 compound.Up to now, the main method that adopts on chemical laboratory and the industrial production is still the degradation method (J.Am.Chem.Soc.1947,69,2167) that chemist Marker provides.Promptly in diacetyl oxide and acetate, pressurize, high temperature (more than 200 ℃) cracking steroid sapogenines becomes corresponding false steroid sapogenines, provides corresponding NSC 37741 through chromic anhydride oxidation and elimination reaction again.Three step total yields are approximately 60%.With the sisalagenin is example, and reaction formula is as follows:
Figure A0111319600031
Though after this this degradation method still fails to change the shortcoming that this method has through updating (Micovic I.V.Synthesis, 1990,591).That is, that fails to remove from office degradation process removes the chromic anhydride oxidizing reaction, and that is to say: the problem of environmental pollution in the steroid sapogenin degradation process still fails to solve.For this reason, the inventor launched the steroid sapogenines resource rational utilization is studied from 1991.Provide after deliberation: by the oxidation of organic peroxide acid to steroid sapogenines, the method for the synthetic NSC 37741 peer-to-peer-pregnen alcohol of basic hydrolysis (Chinese patent, CN96116304.6).Two step total yields can reach more than 90%.With the sisalagenin is example, and reaction formula is as follows:
Figure A0111319600032
This contriver also study provided direct degradation of steroid sapogenin and become the method for corresponding steroidal-22-carboxylic acid-16-alcoholic lactone (Chinese patent, CN00127974.2):
Figure A0111319600041
In the method for the degradation of steroid sapogenin that has provided, they have realized replacing chromic anhydride degradation of steroid sapogenin with hydrogen peroxide, but resulting degraded product can't be directly used in the synthetic of steroid drugs.For the real problem of environmental pollution that solves the steroid sapogenin degradation process, further how research uses the method for pregnen alcohol and steroidal-22-carboxylic acid-16-alcoholic lactone synthesizing steroid medicine, or replaces chromic anhydride degradation of steroid sapogenin to become corresponding NSC 37741 with hydrogen peroxide.In view of NSC 37741 as steroid drugs synthetic key intermediate, be used for steroid drugs production at present, people still expect to have more advanced method to satisfy the development in market.
Order of the present invention provides the method that a kind of degradation of steroid sapogenin becomes NSC 37741.Specifically replace the chromic anhydride false steroid sapogenines of degrading to become the method for corresponding NSC 37741, and obtained satisfied result with hydrogen peroxide.
The inventive method is in organic solvent, in the presence of the metal catalyst or do not have in the presence of the metal catalyst, replace the chromic anhydride false steroid sapogenines of degrading with hydrogen peroxide, add the excessive oxygenant of reductive agent reduction after the reaction, eliminate reaction through parlkaline again and providing NSC 37741.
Figure A0111319600042
This method concrete operations step is as follows:
At first become false steroid sapogenines with reference to existing production method high pressure cracking steroid sapogenines.Oxidation, the elimination reaction of carrying out false steroid sapogenines then just can obtain the NSC 37741 product.
Dissolve false steroid sapogenines in polar solvent, add hydrogen peroxide, metal catalyst and acid, the mol ratio of false steroid sapogenines, hydrogen peroxide, metal catalyst and acid is 1: 1.0-4.0: 0.001-1: 0.0005-10 is recommended as 1: 1-2: 0.01-0.1: 0.001-0.01.Be reflected at 0-80 ℃ and carry out, reaction times 0.1-24 hour.It is complete to raw material reaction that chromatogram tracking reacts.Can in potassium acetate/acetate, reflux after the reaction to make in 1 hour and not eliminate completely that 16-ester group-20-ketone all transforms into NSC 37741.Part acetate is removed in decompression, and residue is handled and obtained required NSC 37741 with organic solvent extraction such as hexanaphthene, ether, sherwood oil, extracting solution.Mother liquor is handled and is obtained 3-methyl-δ-butyrolactone.
Described steroid sapogenines comprises: diosgenin, sisalagenin, zhimusaponin unit, sapogenin that luxuriant numb sapogenin etc. are natural and the sapogenin analogue that is formed by natural sapogenin modification;
Described metal catalyst comprises: tungstic anhydride, tungstate, molybdic acid anhydride, molybdate, phosphomolybdate, heteropolyacid, heteropolyacid salt etc.
Described acid comprises: carboxylic acids such as the phenylformic acid of acetate, formic acid, propionic acid, butyric acid, phenylformic acid, replacement, phthalic acid, m-phthalic acid; Phenylsulfonic acid, to sulfonic acid and derivatives thereof such as methylsulphonic acid Phenylsulfonic acid, fluoro sulfonic acid; Mineral acids such as sulfuric acid, phosphoric acid, phosphorous acid.
Described polar solvent comprises: methylene halide, haloform, ethylene dichloride, acetate, tetrahydrofuran (THF), ether, isopropyl ether, the trimethyl carbinol, dioxane, methyl-sulphoxide, N, proton or aprotic polar solvents such as dinethylformamide, acetone, butanone, acetonitrile, ethyl acetate;
Reductive agent comprises: S-WAT, sodium bisulfite, pyrosulphite hydrogen sodium, Sulfothiorine, vat powder etc.;
Help to understand the present invention by following examples, but be not limited to the present invention.
The oxidative degradation of embodiment 1 false luxuriant numb sapogenin acetic ester and chromic anhydride: the false luxuriant numb sapogenin acetic ester of dissolving 250mg (0.5mmol) is in 1ml acetate, drip chromic anhydride acetic acid solution (112.5mg (1.13mmol) chromic anhydride be dissolved in the 0.9ml acetate promptly), stirring at room reaction 2.5 hours, add 0.05ml formaldehyde decomposing excessive oxygenant, add the 125mg potassium acetate, be warming up to 100 ℃, continued stirring reaction 1 hour, termination reaction.Reaction mixture is removed part acetate through underpressure distillation, after the gained residue impouring frozen water, separates out throw out, filtration, washing, the dry reacting coarse product that gets.Reacting coarse product is through silica gel column chromatography (eluent: petrol ether/ethyl acetate=12/1) obtain 118mg degraded product NSC 37741 acetic ester, yield 65.9%.M.p.162-64 ℃, infrared spectra (ν): 2924,2846,1737,1675,1587,1243,1031cm -1Hydrogen nuclear magnetic resonance spectrum (300NHz, CDCl 3) δ: 6.60 (dd, J=1.3Hz, 1H, 16-H), 4.6 (m, 1H, 3-H), 2.01 (s, 3H, 3-CH 3COO-), 2.26 (s, 3H, CH 3CO-, 21-H), 0.85 (s, 3H, 18-H), 0.88 (s, 3H, 19-H) the ppm. mass spectrum (m/z, %) 417 (M+1), 373 (10.60), 356 (28.36), 281 (15.65), 253 (19.38), 43 (100).
The oxidative degradation of the false luxuriant numb sapogenin acetic ester of embodiment 2 and catalytic amount chromic anhydride and hydrogen peroxide: the luxuriant numb sapogenin acetic ester of dissolving 250mg (0.5mmol) vacation in 1ml acetate, add chromic anhydride (5mg, 0.05mmol), hydrogen peroxide (30%H 2O 2, 204 μ l, 2mmol) acetate (1ml) solution.Reaction mixture after 3 hours, adds the 125mg potassium acetate, 2ml bisulfite saturated aqueous solution of sodium in the stirring at room reaction, continued stirring reaction 1 hour at 100 ℃, acetate is removed in underpressure distillation must react thick 180mg, obtains 103mg NSC 37741 acetic ester, yield 57.5% through silica gel column chromatography again.Spectral data is with embodiment 1.
Embodiment 3 false luxuriant numb sapogenin acetic ester and hydrogen peroxide oxidation DeRs: dissolve the false luxuriant numb sapogenin acetic ester of 250mg (0.5mmol) in 2ml acetate, hydrogen peroxide (30%H 2O 2, 204 μ l, 2mmol).The gained reaction mixture after 2.5 hours, adds the 125mg potassium acetate in the stirring at room reaction, and the saturated aqueous solution of sodium bisulfite of 2ml continued stirring reaction 1 hour at 100 ℃, removed most of solvent under reduced pressure, added frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product 303mg, and (eluent: petrol ether/ethyl acetate=12/1) obtain 80mg degraded product NSC 37741 acetic ester, yield 44.7%. spectral data is with embodiment 1 through silica gel column chromatography.
The oxidative degradation of embodiment 4 false luxuriant numb sapogenin acetic ester and catalytic amount molybdic anhydride and hydrogen peroxide: the false luxuriant numb sapogenin acetic ester of dissolving 125mg (0.25mmol) adds MoO in 2ml acetone 37mg (0.05mmol), 4MH 3PO 41, hydrogen peroxide (30%H 2O 2, 102 μ l, 1mmol).The gained reaction mixture was stirring at room 6 hours, and raw material is complete reaction not, and back flow reaction is 2 hours again, and solids removed by filtration with the filtrate evaporate to dryness of trying one's best, adds the dilution of 2.5ml water, with CH 2Cl 2Extraction, saturated NaCl solution washing, organic phase adds 0.5mlHOAc and 63mg KOAc after steaming and desolventizing, and refluxes 1 hour.Remove most of solvent under reduced pressure, add frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product, through silica gel column chromatography (eluent: petrol ether/ethyl acetate=10/1) obtain 62mg degraded product NSC 37741 acetic ester, yield 68.8%.Spectral data is with embodiment 1.
The oxidative degradation of embodiment 5 false luxuriant numb sapogenin acetic ester and catalytic amount tungstic anhydride and hydrogen peroxide: the false luxuriant numb sapogenin acetic ester of dissolving 500mg (1mmol) adds WO in 8ml acetone 346mg (0.2mmol), 4M H 3PO 44, hydrogen peroxide (30%H 2O 2, 408 μ l, 4mmol), gained reaction mixture refluxed stirring reaction 6 hours.Solids removed by filtration with the filtrate evaporate to dryness of trying one's best, adds the dilution of 10ml water, with CH 2Cl 2Extraction, saturated NaCl solution washing, organic phase adds HOAc2ml and KOAc250mg after steaming and desolventizing, and refluxes 1 hour.Remove most of solvent under reduced pressure, add frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product, through silica gel column chromatography (eluent: petrol ether/ethyl acetate=10/1) obtain 205mg degraded product NSC 37741 acetic ester, yield 58.7%.Spectral data is with embodiment 1.
The oxidative degradation of embodiment 6 false luxuriant numb sapogenin acetic ester and catalytic amount Sodium orthomolybdate and hydrogen peroxide: the false luxuriant numb sapogenin acetic ester of dissolving 500mg (1mmol) adds Na in 8ml acetone 2MoO 42H 2O 48mg (0.2mmol), 4M H 3PO 44, hydrogen peroxide (30%H 2O 2, 408 μ l, 4mmol).Gained reaction mixture refluxed stirring reaction 2.5 hours, solids removed by filtration with the filtrate evaporate to dryness of trying one's best, adds the dilution of 10ml water, with CH 2Cl 2Extraction, saturated NaCl solution washing, organic phase adds HOAc2ml and KOAc250mg after steaming and desolventizing, and refluxes 1 hour.Remove most of solvent under reduced pressure, add frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product, through silica gel column chromatography (eluent: petrol ether/ethyl acetate=10/1) obtain 228mg degraded product NSC 37741 acetic ester, yield 63.4%.Spectral data is with embodiment 1.
The oxidative degradation of embodiment 7 false luxuriant numb sapogenin acetic ester and catalytic amount sodium wolframate and hydrogen peroxide: the false luxuriant numb sapogenin acetic ester of dissolving 500mg (1mmol) adds Na in 8ml acetone 2WO 42H 2O 66mg (0.2mmol), 4M H 3PO 44, hydrogen peroxide (30%H 2O 2, 408 μ l, 4mmol).Gained reaction mixture refluxed stirring reaction 0.5 hour, solids removed by filtration with the filtrate evaporate to dryness of trying one's best, adds the dilution of 10ml water, with CH 2Cl 2Extraction, saturated NaCl solution washing, organic phase adds 2ml HOAc and 250mg KOAc after steaming and desolventizing, and refluxes 1 hour.Remove most of solvent under reduced pressure, add frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product, through silica gel column chromatography (eluent: petrol ether/ethyl acetate=10/1) obtain 180mg degraded product NSC 37741 acetic ester, yield 59.2%.Spectral data is with embodiment 1.
The oxidative degradation of embodiment 8 false luxuriant numb sapogenin acetic ester and catalytic amount sodium wolframate and hydrogen peroxide: the false luxuriant numb sapogenin acetic ester of dissolving 125mg (0.25mmol) adds Na in the 1ml dioxane 2WO 42H 2O 8mg (0.024mmol), 4M H 3PO 41, hydrogen peroxide (30%H 2O 2, 102 μ l, 1mmol).Gained reaction mixture stirring at room reaction 3 days.Solids removed by filtration with the filtrate evaporate to dryness of trying one's best, adds the dilution of 2.5ml water, with CH 2Cl 2Extraction, saturated NaCl solution washing, organic phase adds 0.5mlHOAc and 63mg KOAc after steaming and desolventizing, and refluxes 1 hour.Remove most of solvent under reduced pressure, add frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product, through silica gel column chromatography (eluent: petrol ether/ethyl acetate=10/1) obtain 63mg degraded product NSC 37741 acetic ester, yield 70%.Spectral data is with embodiment 1.
The oxidative degradation of embodiment 9 false luxuriant numb sapogenin acetic ester and catalytic amount sodium wolframate and hydrogen peroxide: with the luxuriant numb sapogenin acetic ester 500mg of vacation (1mmol), trimethyl carbinol 4ml, Na 2WO 42H 2O 33mg (0.1mmol), 4M H 3PO 44, hydrogen peroxide (30%H 2O 2, 408 μ l 4mmol) drop in the reaction flask, gained reaction mixture stirring reaction 5.5 hours in 50 ℃ of oil baths.Solids removed by filtration with the filtrate evaporate to dryness of trying one's best, adds the dilution of 10ml water, with CH 2Cl 2Extraction, saturated NaCl solution washing, organic phase adds HOAc2ml and KOAc250mg after steaming and desolventizing, and refluxes 1 hour.Remove most of solvent under reduced pressure, add frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product, through silica gel column chromatography (eluent: petrol ether/ethyl acetate=10/1) obtain 298mg degraded product NSC 37741 acetic ester, yield 82%.Spectral data is with embodiment 1
The oxidative degradation of embodiment 10 false luxuriant numb sapogenin acetic ester and catalytic amount molybdic anhydride and hydrogen peroxide: with the false luxuriant numb sapogenin acetic ester of 250g (0.5mmol), trimethyl carbinol 2ml, MoO 329mg (0.2mmol), C 6H 5CO 2H 122mg (1mmol), hydrogen peroxide (30%H 2O 2, 204 μ l 2mmol) drop in the reaction flask, gained reaction mixture stirring reaction 4 hours in 50 ℃ of oil baths.Solids removed by filtration with the filtrate evaporate to dryness of trying one's best, adds the dilution of 10ml water, with CH 2Cl 2Extraction, saturated NaCl solution washing, organic phase adds HOAc1ml and KOAc125mg after steaming and desolventizing, and refluxes 1 hour.Remove most of solvent under reduced pressure, add frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product, and (eluent: petrol ether/ethyl acetate=10/1) obtain 156mg degraded product NSC 37741 acetic ester, yield 87.6%. spectral data is with embodiment 1 through silica gel column chromatography
The oxidative degradation of embodiment 11 false luxuriant numb sapogenin acetic ester and catalytic amount molybdic anhydride and hydrogen peroxide: with the false luxuriant numb sapogenin acetic ester of 500mg (1mmol), trimethyl carbinol 4ml, MoO 358mg (0.4mmol), m-phthalic acid 166mg (1mmol), hydrogen peroxide (30%H 2O 2, 408 μ l 4mmol) drop in the reaction flask, gained reaction mixture stirring reaction 3.5 hours in 35 ℃ of oil baths.Add saturated NaHSO 3Solution is removed excessive H 2O 2, to filter, the hexanaphthene extracting of filtrate evaporate to dryness, excess with the extract evaporate to dryness, adds HOAc 4ml, KOAc250mg, back flow reaction 2 hours.Remove most of solvent under reduced pressure, add frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product 506mg, and (eluent: petrol ether/ethyl acetate=10/1) obtain 239mg degraded product NSC 37741 acetic ester, yield 67.1%. spectral data is with embodiment 1. through silica gel column chromatography
The oxidative degradation of embodiment 12 false luxuriant numb sapogenin acetic ester and catalytic amount phospho-molybdic acid and hydrogen peroxide: the false luxuriant numb sapogenin acetic ester of dissolving 500mg (1mmol) adds 186mg H in 2ml acetone 7[(PMo 2O 7) 6] xH 2O (0.1mmol), 4MH 3PO 44, hydrogen peroxide (30%H 2O 2, 408 μ l, 4mmol).Gained reaction mixture stirring at room 4 hours, the raw material unreacted is complete, continues stirring reaction 3 hours in 60 ℃ of oil baths, and solids removed by filtration with the filtrate evaporate to dryness of trying one's best, adds the dilution of 10ml water, with CH 2Cl 2Extraction, saturated NaCl solution washing, organic phase adds 4ml HOAc and 250mg KOAc after steaming and desolventizing, and refluxes 1 hour.Remove most of solvent under reduced pressure, add frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product, through silica gel column chromatography (eluent: petrol ether/ethyl acetate=10/1) obtain 301mg degraded product NSC 37741 acetic ester, yield 84%.Spectral data is with embodiment 1.
The oxidative degradation of embodiment 13 false zhimusaponin unit's acetic ester and catalytic amount molybdic anhydride and hydrogen peroxide: with the false zhimusaponin of 250g (0.5mmol) unit acetic ester, the 2ml trimethyl carbinol, 29mg MoO 3(0.2mmol), 122mg C 6H 5CO 2H (1mmol), hydrogen peroxide (30%H 2O 2, 204 μ l 2mmol) drop in the reaction flask, gained reaction mixture stirring reaction 4 hours in 50 ℃ of oil baths.Solids removed by filtration with the filtrate evaporate to dryness of trying one's best, adds the dilution of 10ml water, with CH 2Cl 2Extraction, saturated NaCl solution washing, organic phase adds 1ml HOAc and 125mg KOAc after steaming and desolventizing, and refluxes 1 hour.Remove most of solvent under reduced pressure, add frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product, through silica gel column chromatography (eluent: petrol ether/ethyl acetate=10/1) obtain 150mg degraded product 5 β-NSC 37741 acetic ester, yield 83.8%.m.p.144-6 ℃, infrared spectra (ν): 2924,2845,1738,1674,1586,1245,1030cm -1Hydrogen nuclear magnetic resonance spectrum (300MHz, CDCl 3) δ: 6.61 (dd, J=1.3Hz, 1H, 16-H), 4.62 (m, 1H, 3-H), 2.01 (s, 3H, 3-CH 3COO-), 2.26 (s, 3H, CH 3CO-, 21-H), 0.84 (s, 3H, 18-H), 0.88 (s, 3H, 19-H) the ppm. mass spectrum (m/z, %) 417 (M+1), 373 (10.60), 356 (28.36), 281 (15.65), 253 (19.38), 43 (100).
The oxidative degradation of embodiment 14 false diosgenin acetic ester and catalytic amount sodium wolframate and hydrogen peroxide: with false diosgenin acetic ester 500mg (1mmol), trimethyl carbinol 4ml, Na 2WO 42H 2O 33mg (0.1mmol), 4M H 3PO 44, hydrogen peroxide (30%H 2O 2, 408 μ l 4mmol) drop in the reaction flask, gained reaction mixture stirring reaction 5.5 hours in 50 ℃ of oil baths.Solids removed by filtration with the filtrate evaporate to dryness of trying one's best, adds the dilution of 10ml water, with CH 2Cl 2Extraction, saturated NaCl solution washing, organic phase adds HOAc2ml and KOAc250mg after steaming and desolventizing, and refluxes 1 hour.Remove most of solvent under reduced pressure, add frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product, through silica gel column chromatography (eluent: petrol ether/ethyl acetate=10/1) obtain the pregnant diketene alcohol acetic ester of 297mg degraded product, yield 82%.M.p.176 ℃, infrared spectra (ν): 2966,2945,1731,1662,1585,1248,1234,1030cm -1Hydrogen nuclear magnetic resonance spectrum (300MHz, CDCl 3) δ: 6.61 (dd, J=1.3Hz, 1H, 16-H), 5.04 (d, J=4Hz, 1H, 6-H), 4.62 (m, 1H, 3-H), 2.01 (s, 3H, 3-CH 3COO-), 2.26 (s, 3H, CH 3CO-, 21-H), 0.84 (s, 3H, 18-H), 0.88 (s, 3H, 19-H) the ppm. mass spectrum (m/z, %) 415 (M+1), 371 (10.60), 354 (28.36), 279 (15.65), 251 (19.38), 43 (100).
The oxidative degradation of embodiment 15 false rockogenin acetic ester and catalytic amount molybdic anhydride and hydrogen peroxide: dissolving 129mg (0.25mmol) rockogenin acetic ester adds 7mg MoO in 2ml acetone 3(0.05mmol), 4MH 3PO 41, hydrogen peroxide (30%H 2O 2, 102 μ l, 1mmol).The gained reaction mixture was stirring at room 6 hours, and raw material is complete reaction not, and back flow reaction is 2 hours again, and solids removed by filtration with the filtrate evaporate to dryness of trying one's best, adds the dilution of 2.5ml water, with CH 2Cl 2Extraction, saturated NaCl solution washing, organic phase adds 0.5mlHOAc and 63mg KOAc after steaming and desolventizing, and refluxes 1 hour.Remove most of solvent under reduced pressure, add frozen water, with CH 2Cl 2Extraction, the extraction liquid washing is dry, and evaporate to dryness gets crude product, through silica gel column chromatography (eluent: petrol ether/ethyl acetate=10/1) obtain 62mg degraded product 12 β-prebediolone acetate alcohol acetic ester, yield 68.8%.M.p.214-5 ℃ of infrared spectra (ν): 2925,2847,1737,1675,1587,1363,1243,1031,984,824,635cm -1Hydrogen nuclear magnetic resonance spectrum (300MHz, CDCl 3) δ: 6.60 (dd, J=1.3Hz, 1H, 16-H), 4.68 (dd, J=11.3,4.6Hz, 1H, 12-H), 4.6 (m, 1H, 3-H), 2.01 (s, 3H, CH 3COO-), 2.04 (s, 3H, CH 3COO-), 2.26 (s, 3H, CH 3CO-, 21-H), 0.85 (s, 3H, 18-H), 0.88 (s, 3H, 19-H) the ppm. mass spectrum (m/z, %) 417 (M+1), 373 (10.60), 356 (28.36), 281 (15.65), 253 (19.38), 43 (100).

Claims (6)

1, the synthetic method of a kind of new NSC 37741 compound, it is characterized in that in polar solvent, the mol ratio of false steroid sapogenines, hydrogen peroxide, metal catalyst and organic or inorganic acid is 1: 1.0-4.0: 0.001-1: during 0.0005-10,0-80 ℃ of reaction 0.1-24 hour; Described steroid sapogenines is a diosgenin, sisalagenin, zhimusaponin unit, the natural sapogenin of luxuriant numb sapogenin or the sapogenin analogue that is formed by natural sapogenin modification; Described metal catalyst is tungstic anhydride, tungstate, molybdic acid anhydride, molybdate, phosphomolybdate, heteropolyacid, heteropolyacid salt.
2, the synthetic method of a kind of new NSC 37741 compound as claimed in claim 1 is characterized in that the mol ratio of described false steroid sapogenines, hydrogen peroxide, metal catalyst and acid is 1: 1-2: 0.01-0.1: 0.001-0.01.
3, the synthetic method of a kind of new NSC 37741 compound as claimed in claim 1, it is characterized in that described organic acid be the carboxylic acid of the phenylformic acid that comprises acetate, formic acid, propionic acid, butyric acid, phenylformic acid, replacement, phthalic acid, m-phthalic acid and comprise Phenylsulfonic acid, to the sulfonic acid and the derivative thereof of methylsulphonic acid Phenylsulfonic acid, fluoro sulfonic acid.
4, the synthetic method of a kind of new NSC 37741 compound as claimed in claim 1 is characterized in that described mineral acid is the mineral acid that comprises sulfuric acid, phosphoric acid, phosphorous acid
5, the synthetic method of a kind of new NSC 37741 compound as claimed in claim 1 is characterized in that after reaction product refluxed 1 hour in potassium acetate/acetate, and part acetate, residue organic solvent extraction are removed in decompression.
6, the synthetic method of a kind of new NSC 37741 compound as claimed in claim 1, it is characterized in that described polar solvent is to comprise methylene halide, haloform, ethylene dichloride, acetate, tetrahydrofuran (THF), ether, isopropyl ether, the trimethyl carbinol, dioxane, methyl-sulphoxide, N, dinethylformamide, acetone, butanone, acetonitrile, ethyl acetate are at interior proton or aprotic polar solvent.
CNB011131969A 2001-06-29 2001-06-29 Synthesis method of pregnen ketoalcohol compound Expired - Fee Related CN1146574C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011131969A CN1146574C (en) 2001-06-29 2001-06-29 Synthesis method of pregnen ketoalcohol compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011131969A CN1146574C (en) 2001-06-29 2001-06-29 Synthesis method of pregnen ketoalcohol compound

Publications (2)

Publication Number Publication Date
CN1341603A true CN1341603A (en) 2002-03-27
CN1146574C CN1146574C (en) 2004-04-21

Family

ID=4659938

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011131969A Expired - Fee Related CN1146574C (en) 2001-06-29 2001-06-29 Synthesis method of pregnen ketoalcohol compound

Country Status (1)

Country Link
CN (1) CN1146574C (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007668A1 (en) * 2003-07-16 2005-01-27 Shanhghai Institute Of Organic Chemistry, Chinese Academy Of Sciences A production process for 16-dehydropregnenoneol and its analogs
CN101974057A (en) * 2010-10-13 2011-02-16 天津大学 Preparation method of 16-dehydropregnenolone acetate and 16-dehydropregnenolone acetate congeners
CN102286052A (en) * 2011-07-13 2011-12-21 中国科学院上海有机化学研究所 Method for synthetising pregnenolol compound
CN102329368A (en) * 2011-07-13 2012-01-25 中国科学院上海有机化学研究所 20 alpha,22 beta,23 alpha-trihydroxy steroidal compound, and synthesis method and application thereof
CN102391343A (en) * 2011-08-31 2012-03-28 天津大学 Method for synthetizing dehydropregnenolone acetate and isotype substance thereof
CN103864873A (en) * 2014-04-02 2014-06-18 中国科学院上海有机化学研究所 16-(2'-hydroxyl-4'-methyl-5'-acetoxyl) amyl acyloxy acetic acid progesterone alcohol compound as well as synthetic method and application thereof
CN105111268A (en) * 2015-09-22 2015-12-02 武汉工程大学 Preparation method of dehydropregnenolone acetate

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007668A1 (en) * 2003-07-16 2005-01-27 Shanhghai Institute Of Organic Chemistry, Chinese Academy Of Sciences A production process for 16-dehydropregnenoneol and its analogs
CN101974057A (en) * 2010-10-13 2011-02-16 天津大学 Preparation method of 16-dehydropregnenolone acetate and 16-dehydropregnenolone acetate congeners
CN102286052A (en) * 2011-07-13 2011-12-21 中国科学院上海有机化学研究所 Method for synthetising pregnenolol compound
CN102329368A (en) * 2011-07-13 2012-01-25 中国科学院上海有机化学研究所 20 alpha,22 beta,23 alpha-trihydroxy steroidal compound, and synthesis method and application thereof
CN102286052B (en) * 2011-07-13 2013-03-06 中国科学院上海有机化学研究所 Method for synthetising pregnenolol compound
CN102391343A (en) * 2011-08-31 2012-03-28 天津大学 Method for synthetizing dehydropregnenolone acetate and isotype substance thereof
CN103864873A (en) * 2014-04-02 2014-06-18 中国科学院上海有机化学研究所 16-(2'-hydroxyl-4'-methyl-5'-acetoxyl) amyl acyloxy acetic acid progesterone alcohol compound as well as synthetic method and application thereof
CN105111268A (en) * 2015-09-22 2015-12-02 武汉工程大学 Preparation method of dehydropregnenolone acetate

Also Published As

Publication number Publication date
CN1146574C (en) 2004-04-21

Similar Documents

Publication Publication Date Title
CN1146574C (en) Synthesis method of pregnen ketoalcohol compound
Schultz et al. 2, 5-Cyclohexadien-1-one to bicyclo [3.1. 0] hexenone photorearrangement. Development of the reaction for use in organic synthesis
JP5309318B2 (en) Process for producing esters, carboxylic acids and amides
Liu et al. Hydration of unsymmetrical internal alkynes: factors governing the regioselectivity
CN112225652B (en) Preparation and application of tetracarbonyl cyclobutane compound dihydrate
Shen et al. Proline-catalyzed aldol reactions of acyl cyanides with acetone: an efficient and convenient synthesis of 1, 3-diketones
CN108821975A (en) A kind of hydrogenation phenanthrene derivatives and preparation method thereof containing exocyclic double bond
CN109734571B (en) Method for synthesizing alpha-F-beta-OH-carbonyl compound
EP3560942A1 (en) Xylose derivatives and process for preparation thereof
CN109456221A (en) A kind of synthetic method of acetanilide derivative
DE10131810A1 (en) Process for the production of optically active cyanohydrins and their corresponding acids
CN112939855B (en) Process for preparing 1, 4-dihydropyridine derivatives containing azulene ring structure
DE69230283T2 (en) METHOD FOR PRODUCING SPIROKETALES
Taj et al. Asymmetric methylene transfer reactions II: Asymmetric synthesis of oxiranes from carbonyl compounds by methylene transfer reaction using chiral S-neomenthyl and S-exo-2-bornyl sulfoximines
Yu et al. Organic syntheses via transition metal complexes, LXXXVIII 1-Metalla-1, 3, 5, 7-octatetraenes from (1-alkynyl) carbene complexes of chromium and tungsten via [6-(1-alkenyl)] pyranylidene complexes
DE10335417A1 (en) Production of ruthenium complex for use as metathesis catalyst, involves Claisen rearrangement of allyl phenyl ether, double bond isomerisation and alkylation to a 2-propenyl-phenoxy compound, and ligand exchange
EP1248775B1 (en) Method for the enantioselective preparation of 3,3-diphenyl-2,3-epoxy propionic acid esters
CN1183103C (en) Method for producing cyanoacetic acid esters
CN116332740A (en) Preparation method of oxymetazoline hydrochloride impurity A
Li et al. Trimerization of aldehydes with one α-hydrogen catalyzed by sodium hydroxide
CN112159344B (en) Synthesis method of 1, 3-dimethyl-3-hydroxymethyl indoline-2-ketone compound
CN111606895B (en) Synthesis method of 1-alkyl-isoquinoline compound
CN111138315B (en) Cyanoalkyl substituted quinone compound and synthesis method thereof
Angert et al. Chelate‐Controlled Additions of Titanium and Lithium Enolates to Chiral β‐Formyl Esters–Diastereofacial and Simple Diastereoselectivity
CN106588812B (en) A kind of method of acyl chlorides preparation 2,4- disubstituted thiazolines class compound

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040421

Termination date: 20200629